NCT06705075View on ClinicalTrials.gov

Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

September 30, 2026

Conditions
Uterine Fibroid
Interventions
DRUG

Perfluten

Use of UCA Definity to evaluate uterine fibroids by contrast-enhanced ultrasound (CEUS) and subharmonic-aided pressure estimation (SHAPE) pre and post-uterine artery embolization (UAE).

Trial Locations (1)

19107

RECRUITING

Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER